Lansdowne, PA, United States of America

Michael March

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations by Michael March in Lymphatic System Disorders

Introduction

Michael March is an accomplished inventor based in Lansdowne, PA (US). He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of lymphatic system disorders. With a total of two patents to his name, March's work is paving the way for advancements in healthcare.

Latest Patents

Michael March's latest patents include innovative compositions and methods for the diagnosis and treatment of lymphatic system disorders. One patent focuses on compositions and methods for the diagnosis and treatment of lymphatic anomalies. The second patent addresses the treatment of hereditary cystatin C amyloid angiopathy (HCCAA) and other neurodegenerative disorders associated with aberrant amyloid deposits. These patents highlight his commitment to addressing complex medical challenges.

Career Highlights

March is affiliated with The Children's Hospital of Philadelphia, where he applies his expertise to improve patient outcomes. His work is characterized by a dedication to research and innovation in the medical field.

Collaborations

Michael March collaborates with notable colleagues, including Hakon Hakonarson and Alvaro Gutierrez-Uzquiza. Their combined efforts contribute to the advancement of medical research and the development of new treatment methodologies.

Conclusion

Michael March's contributions to the field of medical research, particularly in lymphatic system disorders, demonstrate his innovative spirit and commitment to improving healthcare. His patents reflect a significant step forward in the diagnosis and treatment of complex medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…